GlassScriptPhysician profile
Nicole E Quinn
NPI 1932464617
$1,943.42
in general payments reported to CMS, 2019-2025
29 companies · $170 in 2025
The $170 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $193 · 2020: $185 · 2021: $412 · 2022: $471 · 2023: $243 · 2024: $271 · 2025: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $683.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $683.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $362.99 | 2019-2024 | Veozah, Myrbetriq |
| Abbvie INC. | $295.58 | 2019-2023 | |
| Therapeuticsmd, INC. | $127.98 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $115.43 | 2024-2025 | Myfembree |
| Exeltis, USA INC. | $100.11 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $99.42 | 2021-2025 | |
| Hologic Sales and Service, LLC | $85.06 | 2019-2024 | Aptima |
| Aspira Women'S Health INC | $82.08 | 2022 | |
| Pfizer INC. | $62.92 | 2023-2024 | |
| Minerva Surgical, INC | $58.94 | 2021-2024 | |
| Mylan Pharmaceuticals INC. | $54.63 | 2021-2022 | |
| Avion Pharmaceuticals | $52.82 | 2019-2022 | |
| Boston Scientific Corporation | $49.00 | 2020-2022 | |
| Daiichi Sankyo INC. | $47.91 | 2019-2020 | |
| Allergan, INC. | $39.31 | 2019-2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics Corporation | $37.98 | 2019 | |
| Meditrina | $36.41 | 2024-2025 | |
| Coopersurgical, INC. | $33.37 | 2021-2023 | Advincula Delineator Uterine Manipulator |
| Biogen, INC. | $23.59 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.02 | 2025 | |
| Agile Therapeutics, INC. | $21.13 | 2021 | |
| Millicent US INC | $20.33 | 2025 | Intrarosa |
| Optumhealth Care Solutions, LLC | $19.99 | 2024 | Vivify Health Care Team Portal 001, Eitan Medical |
| Baxter Healthcare | $19.71 | 2024 | Perclot |
| Evofem Biosciences, INC. | $18.20 | 2021 | |
| Scynexis, INC. | $14.72 | 2022 | |
| Acessa Health INC. | $14.52 | 2021 | |
| Glaxosmithkline, LLC. | $14.46 | 2019 | |
| Medtronic, INC. | $11.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Quinn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.